Tumor Blood-Vessel Growth Influenced By Cancer-Killing Viruses
Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor.The findings of an animal study by researchers at the Ohio State University Comprehensive Cancer Center help explain why this happens and could improve this therapy for brain cancer patients.
'Addicted' Cells Provide Early Cancer Diagnosis
Scientists at the Institute of Food Research have detected subtle changes that may make the bowel more vulnerable to the development of tumours.With support from the Food Standards Agency and the Biotechnology and Biological Sciences Research Council they are investigating whether diet could control these changes and delay or reverse the onset of cancer.
Oncothyreon Initiates Phase 1b Trial Of PX-12 In Patients With Advanced Metastatic Cancer
Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) (the "Company") announced that the first patient has been treated in a Phase 1b clinical trial of PX-12 in patients with advanced metastatic cancer. PX-12 is a proprietary small molecule inhibitor of thioredoxin, a protein that regulates diverse molecular pathways that contribute to the growth, survival and drug resistance of many cancers.
Researchers Publish End Of Life Chemotherapy Guidance
Physician-researchers from the Virginia Commonwealth University Massey Cancer Center home to one of the nation's leading cancer palliative care programs -- published a case study in today's issue of the Journal of the American Medical Association (JAMA) exploring the role of chemotherapy given in the last phases of life to cancer patients in the United States.
Reconnecting With Cancer Survivors: Suggestions On Adjusting To Life After Treatment
More people in the U.S. are living longer after a cancer diagnosis. For this increasing number of cancer survivors, living a better quality of life is just as important as living through the disease. Improving communication and acknowledging stress can enhance the quality of life of cancer survivors and those who support them.
Laparoscopic Nephroureterectomy Vs. Standard Nephroureterectomy For Upper Urinary Tract Transitional Cell Carcinoma
ORLANDO, FL (UroToday.com) - To reveal the oncological safety of laparoscopic nephroureterectomy (LNU), a group of Japanese researchers compared the long-term oncological outcome of laparoscopic versus open nephroureterectomy (ONU) in patients with upper tract transitional cell carcinoma (TCC).
Concomitant Microscopic Tumor Deposits Accompanying Overt Testicular Cancer
ORLANDO, FL (UroToday.com) - Are we leaving cancer behind? Testis-sparing surgery is gaining momentum for treatment of small/localized testicular tumors. Ehrlich and colleagues identified 145 patients who underwent orchiectomy for germ cell tumor. The investigators re-reviewed the pathologic specimens from these patients and evaluated whether any satellite tumor sites were present in addition to the primary mass.
Smad For MicroRNA Processing
Researchers at Tufts University School of Medicine and Tufts Medical Center have found that Smad proteins regulate microRNA (miRNA) processing. Understanding the role of Smad proteins enables researchers to investigate abnormal miRNA processing which is a contributing factor in development of cardiovascular disorders and cancer.
Neoprobe Commences Lymphoseek Phase 3 Trial
Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that a multicenter Phase 3 study of Lymphoseek has been initiated in patients with either breast cancer or melanoma.
Researchers Identify Biomarkers Of Early-stage Pancreatic Cancer In Mice And Man
A multicenter team of researchers has identified a panel of proteins linked to early development of pancreatic cancer in mice that applies also to early stages of the disease in humans a breakthrough that brings scientists a significant step closer to developing a blood test to detect the disease early, when cure rates are highest.